A detailed history of Jpmorgan Chase & CO transactions in Stryker Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 8,651,403 shares of SYK stock, worth $2.95 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares
8,651,403
Previous 7,838,092 10.38%
Holding current value
$2.95 Billion
Previous $2.35 Billion 31.91%
% of portfolio
0.28%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$293.94 - $358.71 $239 Million - $292 Million
813,311 Added 10.38%
8,651,403 $3.1 Billion
Q4 2023

Feb 12, 2024

BUY
$253.85 - $299.46 $1.12 Billion - $1.33 Billion
4,427,566 Added 129.82%
7,838,092 $2.35 Billion
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $264 Million - $300 Million
990,979 Added 40.96%
3,410,526 $932 Million
Q2 2023

Aug 11, 2023

BUY
$271.49 - $305.09 $109 Million - $122 Million
400,673 Added 19.85%
2,419,547 $738 Million
Q1 2023

May 18, 2023

BUY
$246.13 - $285.47 $39.1 Million - $45.3 Million
158,670 Added 8.53%
2,018,874 $576 Million
Q1 2023

May 11, 2023

BUY
$246.13 - $285.47 $135 Million - $156 Million
548,169 Added 41.78%
1,860,204 $531 Million
Q4 2022

Feb 13, 2023

BUY
$205.51 - $253.93 $105 Million - $129 Million
509,000 Added 63.38%
1,312,035 $321 Million
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $20.5 Million - $25.2 Million
108,526 Added 15.63%
803,035 $163 Million
Q2 2022

Aug 11, 2022

SELL
$194.09 - $276.37 $16.5 Million - $23.5 Million
-85,158 Reduced 10.92%
694,509 $138 Million
Q1 2022

May 11, 2022

BUY
$245.33 - $277.77 $9.63 Million - $10.9 Million
39,256 Added 5.3%
779,667 $208 Million
Q4 2021

Feb 10, 2022

BUY
$236.63 - $276.44 $47.3 Million - $55.2 Million
199,704 Added 36.93%
740,411 $198 Million
Q3 2021

Nov 12, 2021

BUY
$248.9 - $280.09 $135 Million - $151 Million
540,707 New
540,707 $143 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $129B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.